首页> Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico> Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Teresa,Alonso-Gordoa

第一单位： Department of Medical Oncology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

作者： Teresa,Alonso-Gordoa ^[1] ; Ovidio,Fernández-Calvo ^[2] ; Icíar,García-Carbonero ^[3] ; Sara,Álvarez-Rodríguez ^[4] ; Ricardo,Sánchez-Escribano ^[5] ; Georgia,Anguera ^[6] ; Aránzazu,González-Del-Alba ^[7] ; Enrique,Gallardo ^[8] ; Diego,Cacho ^[9] ; Natalia,Vidal ^[10] ; Álvaro,Pinto ^[11] ; Carmen,Perezagua ^[12] ; Marta,Zafra-Poves ^[13] ; Javier,Cassinello ^[14] ; Alejo,Rodriguez-Vida ^[15] ; Fernando,López-Campos ^[16] ; Sergio,Vázquez-Estévez ^[17]

作者单位： Department of Medical Oncology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. ^[1] Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. ^[2] Department of Oncology, Hospital Universitario de Toledo, Toledo, Spain. ^[3] Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. ^[4] Department of Oncology, Hospital Universitario de Burgos, Burgos, Spain. ^[5] Department of Medical Oncology, Hospital de La Santa Creu i Sant Pau, Barcelona, Spain. ^[6] Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. ^[7] Department of Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain. ^[8] Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. ^[9] Department of Medical Oncology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain. ^[10] Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. ^[11] Department of Medical Oncology, Hospital Universitario del Henares, Madrid, Spain. ^[12] Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain. ^[13] Department of Medical Oncology, Hospital Universitario de Guadalajara, Guadalajara, Spain. ^[14] Department of Medical Oncology, Hospital Del Mar, CIBERONC, Barcelona, Spain. ^[15] Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.;Genesis Care Vithas La Milagrosa, Madrid, Spain. ^[16] Department of Medical Oncology. Hospital, Universitario Lucus Augusti, Rúa Dr. Ulises Romero, 1, 27003, Lugo, Spain. Sergio.Vazquez.Estevez@sergas.es. ^[17]

关键词 Castration-sensitive prostate cancer Darolutamide Hormone-sensitive prostate cancer Patient selection Prostatic neoplasms (MeSH term)Treatment pattern Triplet therapy